In Vivo is the senior executives' resource for informed, effective, profitable decision-making because it delivers the insight they need to construct winning strategies, combat competitors' plans, and anticipate future industry and market developments.

The Pink Sheet is where you will find the forward looking insights and lessons learned that biopharma leaders need to inform their decision making and strategic planning from a policy and regulatory perspective, keep themselves and their companies out of trouble and in compliance, and get their products approved. More than just news, Pink Sheet delivers analysis, and commentary focused on regulatory implications, including high value perspectives from insiders and thought leaders across the globe - giving regulatory professionals an objective view of how to anticipate challenges, minimize risks, and maximize opportunities. (Source: Nexis Uni)